Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.Juanita Lopez, Joachim P. Steinbach, Paul M. Clément et al.|Journal of Clinical Oncology|2023Cited by 1
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinomaSimon Haefliger, Roland Giger, Ruben Bill et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 1